Company: LDDD
Filing Date: 2025-09-26
Form Type: 10-K
Source: 0001213900-25-091988
Chunk: 15

Company: Longduoduo Co Ltd
Filing Date: 2025-09-26
Form: 10-K
Item: Item 1
Chunk 15
---
 has not had any income (loss) subject to the Hong Kong profits tax.

China

Julong
and its subsidiaries are subject to a 25% standard enterprise income tax in the PRC. The Company accrued $222,268 and $523,207 of PRC
income tax for the years ended June 30, 2025 and 2024.

Employees

The
Company has 52 full-time employees. Of those 49, Qingguo has 10 full-time employees, Rongbin has 14 full-time employees, Chengheng has
6 full-time employees, Tianju has 6 full-time employees and Longduoduo Health Technology has 16 full-time employees.

The
Company’s employees include 10 with management responsibilities, 19 with administrative and operations responsibilities, and 23
responsible for customer services.

All
of our employees are located in the PRC. None of our employees are represented by a labor union or similar collective bargaining organization.

11

Item
1A. Risk Factors.

An
investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors and other information
in this 10K before deciding to invest in our Company. If any of the following risks actually occur, our business, financial condition
and results of operations could be seriously harmed. As a result, the trading price of our common stock could decline and you could lose
all or part of your investment.

Risks
Related to Our Business

97%
of our revenue during the year ended June 30, 2025 came from a single source: Inner Mongolia Honghai Health Management Co., Ltd. Termination
of our relationship with Honghai would likely have serious adverse effects on our financial results.

In
June 2023 each of our operating subsidiaries entered into identical Sales Agency Agreements with Inner Mongolia Honghai Health Management
Co., Ltd. (“Honghai”), pursuant to which our operating subsidiaries serve as sales agents for services provided by Honghai
and receive commissions on the sales they initiate. During the year ended June 30, 2025, commissions from sales on behalf of Honghai
represented over 97% of our Company’s revenues, while revenues from principal sales, our focus before engaging with Honghai, fell
by almost 63%.

The
Sales Agency Agreements terminate in June 2026, and there is no certainty that our relationship with Honghai will continue past that
date In addition, any number of factors could interfere with